IBM's quantum computing is helping make drug development more efficient

IBM reports its quantum systems are being used by researchers for molecular and drug research, and five of six finalists in the Quantum for Bio challenge used IBM's systems.

IBM is showing that its quantum computing technology is beginning to be used in healthcare and biology research. The company says quantum systems can now tackle problems that are too complex for traditional computers. Researchers are beginning to apply the technology to studies of molecules and to drug development. IBM is also running and supporting programs such as the Quantum for Bio challenge to advance that work. Key points: - IBM reports its quantum systems can handle problems beyond traditional computers. - Researchers are applying quantum computing to molecular studies and drug development. - Five of six finalists in the Quantum for Bio challenge used IBM's quantum systems. - The program is funded and focuses on building tools that could run on quantum hardware within three to five years. - IBM describes a hybrid approach that combines quantum and classical computing rather than replacing existing systems. - The article mentions analysts have a moderate consensus based on recent ratings. Summary: IBM's work is reported as helping move research ideas toward real-world testing and could affect how complex biological data is analyzed. The article reports the Quantum for Bio program aims to produce tools that can realistically run on quantum machines within three to five years, and IBM expects quantum to be used alongside traditional systems.